title: Tolerance of fragranced and fragrance-free facial cleansers in adults with clinically sensitive skin.
abstract: Although mild, fragrance-free, nonfoaming cleansers generally are recommended for individuals with sensitive skin, many consumers choose fragranced foaming cleansers. The addition of hydrophobically modified polymers (HMPs) to mild facial cleansers has been shown to improve product tolerability in individuals with sensitive skin while facilitating foaming. The objective of the 2 studies reported here was to assess the tolerability of a mild, HMP-containing, foaming facial cleanser with a fragrance that was free of common allergens and irritating essential oils in patients with sensitive skin. In the first study, 8 participants with clinically diagnosed fragrance sensitivity used a gentle foaming HMP-containing facial cleanser with or without fragrance for 3 weeks. Both cleansers improved global disease severity, irritation, and erythema with similar cleansing effectiveness. The second study was a 3-week, prospective, double-blind, randomized, 2-center study of 153 participants with clinically diagnosed sensitive skin. In this study, the fragranced gentle foaming cleanser with HMP was as well tolerated as a benchmark gentle, fragrance-free, nonfoaming cleanser. Itching, irritation, and desquamation were most improved from baseline in both groups. The participant-rated effectiveness of the cleanser with HMP was similar or better than the benchmark cleanser after 3 weeks of use. In conclusion, the gentle facial cleanser with HMPs and a fragrance offers a new option for adults with sensitive skin who may prefer, and commonly use, a fragranced and foaming product.
authors.affiliation: Dermatology Consulting Services, High Point, North Carolina, USA.
authors.forename: Zoe D
authors.initials: ZD
authors.lastname: Draelos
authors.affiliation: Dermatology Specialists, PSC, Louisville, Kentucky, USA.
authors.forename: Joseph
authors.initials: J
authors.lastname: Fowler
authors.affiliation: Portland Dermatology Clinic, Oregon, USA.
authors.forename: Walter G
authors.initials: WG
authors.lastname: Larsen
authors.affiliation: Johnson & Johnson Consumer Inc, Skillman, New Jersey, USA.
authors.forename: Sidney
authors.initials: S
authors.lastname: Hornby
authors.affiliation: Johnson & Johnson Consumer Inc, Skillman, New Jersey, USA.
authors.forename: Russel M
authors.initials: RM
authors.lastname: Walters
authors.affiliation: Johnson & Johnson Consumer Inc, Skillman, New Jersey, USA.
authors.forename: Yohini
authors.initials: Y
authors.lastname: Appa
mesh_terms: D000328:Adult; D018592:Cross-Over Studies; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000737:chemistry; D004311:Double-Blind Method; D004890:Erythema / Q000139:chemically induced; D005260:Female; D006801:Humans; D008875:Middle Aged; D010476:Perfume / Q000009:adverse effects / Q000737:chemistry*; D011446:Prospective Studies; D012867:Skin / Q000473:pathology*; D017592:Skin Care / Q000009:adverse effects / Q000379:methods*; D055815:Young Adult
chemical_list: D003879:Dermatologic Agents; D010476:Perfume